RFG Advisory LLC Makes New $1.12 Million Investment in SPDR S&P Biotech ETF $XBI

RFG Advisory LLC acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 7,063 shares of the exchange traded fund’s stock, valued at approximately $1,118,000.

Other hedge funds also recently made changes to their positions in the company. NewEdge Advisors LLC boosted its stake in shares of SPDR S&P Biotech ETF by 34.6% during the 2nd quarter. NewEdge Advisors LLC now owns 27,420 shares of the exchange traded fund’s stock worth $4,339,000 after acquiring an additional 7,050 shares during the period. IFP Advisors Inc increased its holdings in shares of SPDR S&P Biotech ETF by 20.4% during the 2nd quarter. IFP Advisors Inc now owns 21,192 shares of the exchange traded fund’s stock worth $3,354,000 after acquiring an additional 3,590 shares during the last quarter. Waverly Advisors LLC raised its stake in SPDR S&P Biotech ETF by 29.6% in the 2nd quarter. Waverly Advisors LLC now owns 3,524 shares of the exchange traded fund’s stock valued at $558,000 after acquiring an additional 805 shares during the period. HighTower Advisors LLC raised its stake in SPDR S&P Biotech ETF by 10.7% in the 2nd quarter. HighTower Advisors LLC now owns 90,861 shares of the exchange traded fund’s stock valued at $14,379,000 after acquiring an additional 8,780 shares during the period. Finally, Tobias Financial Advisors Inc. acquired a new stake in SPDR S&P Biotech ETF during the 2nd quarter valued at $214,000.

SPDR S&P Biotech ETF Price Performance

XBI stock opened at $156.20 on Friday. SPDR S&P Biotech ETF has a one year low of $92.64 and a one year high of $169.89. The stock has a market cap of $10.20 billion, a price-to-earnings ratio of 11.47 and a beta of 0.84. The company has a fifty day moving average price of $158.26 and a two-hundred day moving average price of $141.72.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.